Latest Data & Signals Issued
|Signal Type||Signal Value||Data|
|Score||-0.300||9 days ( -5.26 % )|
|Last Price||$1.40||-1.41 %|
|High/ Low||$1.34 - $1.43||-1.49%|
|Chg 7 Days||-16.17 %||$1.67 $1.40|
|Chg 30 Days||38.61 %||$1.01 $1.40|
|Chg 12 mos||81.82 %||$0.770 $1.40|
|Trend - 3 mos||-3.45 %||Width: 105.91 %|
|Trend - 12 mos||15.20 %||Width: 1196.19 %|
|Pred. range - 3 mos||$0.781 - $1.61||-44.22 % - 14.85 %|
|Pred. range - 12 mos||$0.619 - $8.02||-55.78 % - 473.19 %|
|Short mv avg 3 mos||Sell||2023-09-19 - 4 days|
|Long mv avg 3 mos||Buy||2023-09-07 - 12 days|
|Short/Long mv avg 3 mos||Buy||2023-09-12 - 9 days|
|Short mv avg 12 mos||Buy||2023-09-07 - 12 days|
|Long mv avg 12 mos||Sell||2023-09-20 - 3 days|
|Short/Long mv avg 12 mos||Sell||2023-08-10 - 31 days|
|Pivot Short||Sell||2023-09-15 - 6 days|
|Bollinger||Buy||2023-03-09 - 137 days|
|MACD||Buy||No Dates Stored For This Signal|
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
Moving Average (7d)
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The compa... BIOC Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.